Asset Team Lead (ATL), Skeletal Conditions Business Unit
BioMarin Pharmaceutical Inc.
August 31, 2026
Remote friendly (United States)
United States
Operations
Asset Team Lead (ATL), Skeletal Conditions Business Unit
What You’ll Own
- Lead development and execution of an integrated asset strategy aligned to Business Unit priorities, portfolio objectives, and enterprise goals.
- Shape the strategy across the asset lifecycle (development through commercialization and lifecycle management).
- Evaluate opportunities, risks, and tradeoffs to inform critical decisions and optimize long-term value.
- Ensure alignment among strategic priorities, resource allocation, timelines, and financial plans.
- Lead a high-performing, cross-functional Asset Team; create alignment on priorities, key decisions, and execution plans.
- Foster trust, transparency, accountability, and productive debate; build partnerships for timely escalation and resolution.
- Drive timely, high-quality decision-making through governance forums and executive interactions.
- Champion the asset and communicate strategy, risks, tradeoffs, and recommendations clearly.
- Translate strategy into coordinated action; establish priorities and accountability for milestones and deliverables.
- Monitor progress, anticipate obstacles, adapt plans, and drive urgency while maintaining scientific rigor, quality, and compliance.
Qualifications
Required
- 10+ years’ experience in biotechnology/pharmaceutical/healthcare (or related).
- 5+ years leading complex cross-functional initiatives/teams in a matrixed environment.
- Demonstrated success influencing decisions, driving alignment, and delivering results across multiple functions.
- Strong strategic thinking and problem-solving; balance short-term execution with long-term value.
Preferred
- Experience in product development, commercialization, medical affairs, portfolio strategy, business leadership (or related).
- Experience leading an Asset Team or similarly complex cross-functional organization.
- Understanding of biopharmaceutical product lifecycle from development through commercialization and lifecycle management.
What You’ll Own
- Lead development and execution of an integrated asset strategy aligned to Business Unit priorities, portfolio objectives, and enterprise goals.
- Shape the strategy across the asset lifecycle (development through commercialization and lifecycle management).
- Evaluate opportunities, risks, and tradeoffs to inform critical decisions and optimize long-term value.
- Ensure alignment among strategic priorities, resource allocation, timelines, and financial plans.
- Lead a high-performing, cross-functional Asset Team; create alignment on priorities, key decisions, and execution plans.
- Foster trust, transparency, accountability, and productive debate; build partnerships for timely escalation and resolution.
- Drive timely, high-quality decision-making through governance forums and executive interactions.
- Champion the asset and communicate strategy, risks, tradeoffs, and recommendations clearly.
- Translate strategy into coordinated action; establish priorities and accountability for milestones and deliverables.
- Monitor progress, anticipate obstacles, adapt plans, and drive urgency while maintaining scientific rigor, quality, and compliance.
Qualifications
Required
- 10+ years’ experience in biotechnology/pharmaceutical/healthcare (or related).
- 5+ years leading complex cross-functional initiatives/teams in a matrixed environment.
- Demonstrated success influencing decisions, driving alignment, and delivering results across multiple functions.
- Strong strategic thinking and problem-solving; balance short-term execution with long-term value.
Preferred
- Experience in product development, commercialization, medical affairs, portfolio strategy, business leadership (or related).
- Experience leading an Asset Team or similarly complex cross-functional organization.
- Understanding of biopharmaceutical product lifecycle from development through commercialization and lifecycle management.